The Hindu Business Line : Cipla slashes anti-AIDS drug prices by 30%

In a letter to doctors, the company said that patients could save more than Rs 360 per month on combination drugs such as Triomune and about Rs 450 per month on another anti-AIDS drug Duovir.

Triomune is a combination or a three-in-one pill combining Lamivudine, Stavudine and Nevirapine. Given the standard regimen of these drugs, Cipla indicated that the new cost per month of Triomune would be about Rs 1,239. This stands compared to its earlier cost of Rs 1,602 per month.

Duovir combines Lamivudine, Zidovudine and Nevirapine and the new cost to the patient is Rs 1,350, compared to the previous cost of Rs 1,800, the Cipla note said.

"The price cuts are part of the company's commitment to AIDS patients and we have been slashing prices over the last four years. We are looking at making the drugs more affordable to patients and there is no other reason behind the timing of these announcements," Mr Amar Lulla, Joint Managing Director of Cipla, told Business Line. Responding to the toll price cuts will take on the company's revenues, he said: "We are not looking at the issue from a revenue stand point. The company has been doing this over the last several years."

More Stories on : Pharmaceuticals | Announcements | Stocks | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Forex reserves rise by $1 b

Cipla slashes anti-AIDS drug prices by 30%

Zee emerges highest bidder with Rs 1,206 cr

Directors' pay rises faster than staff's

GTB is history; Oriental Bank takes charge of operations

`GTB staff to be retained at same salary for 3 years'